返回期刊详情

IF0

论文数1

被引数0

期刊论文 1

发表时间

High-Dose 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration: Who Is Being Treated with This New Agent?高剂量8 mg Aflibercept治疗新生血管性年龄相关性黄斑变性：哪些患者正在接受这种新药治疗？

Life 2025, Vol. 15, Page 1657

IF0

2025-10-23

OAAI

Caspar Liesenhoff; Carolin Meyrl; Daniel Krause; Franziska Eckardt; Anna Lorger; Viktoria Deiters; Johannes Schiefelbein; Julian Elias Klaas; Benedikt Schworm; Siegfried G. Priglinger; Jakob Siedlecki